← All trials
NCT00624845
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2007
- Primary completion
- May 31, 2009
- Completion date
- May 31, 2009
- First posted
- Feb 27, 2008
- Last posted
- Jun 27, 2011
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Omeros CorporationLead sponsor
- Omeros CorporationSponsor investigator
- Omeros CorporationStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.